Acciones Eidos Therapeutics, Inc.
Acciones
EIDX
US28249H1041
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |